Every new medicine reaches the clinic the same way — through a disciplined sequence of preclinical testing and then clinical trials in phases, all governed by Good Clinical Practice (GCP). This is the foundation topic for the Clinical Research paper: get the phases, the ethics and the ICH framework clear and the rest of the syllabus falls into place.
What is clinical research?
Clinical research is the systematic study of the safety and efficacy of drugs, devices, diagnostics and treatment regimens in human subjects. The ICH-GCP definition of a clinical trial is any investigation in human subjects intended to discover or verify the clinical, pharmacological or pharmacodynamic effects of an investigational product, and/or identify adverse reactions, and/or study its ADME — to ascertain safety and/or efficacy. (“Clinical trial” and “clinical study” are synonymous.)
Types of clinical research
- Observational — the investigator does not allocate the intervention: cohort, case-control, cross-sectional, and case series/report studies.
- Interventional / experimental — the investigator assigns the intervention: randomised controlled trials (RCTs) and non-randomised trials.
- By objective — therapeutic, diagnostic, preventive (vaccines), screening, and supportive-care / quality-of-life research.
- Therapeutic vs non-therapeutic — whether the subject may directly benefit from participating.
Phases of clinical trials
| Phase | Subjects (n) | Primary purpose |
|---|---|---|
| Phase 0 | Healthy, ~10 (microdose) | Exploratory human PK/PD with sub-therapeutic microdoses (≤100 µg); no efficacy/safety claim. |
| Phase I | Healthy, 20–80 (patients for cytotoxics) | First-in-human safety, tolerability, PK/PD, dose-ranging and maximum tolerated dose (MTD). |
| Phase II | Patients, 100–300 | Proof-of-concept efficacy, dose-finding (IIa dose, IIb efficacy) and short-term safety. |
| Phase III | Patients, 300–3000+ | Confirmatory efficacy vs placebo/standard; basis for marketing approval. Multicentric RCTs. |
| Phase IV | Real-world, large population | Post-marketing surveillance — rare/long-term ADRs, interactions, new indications. |
India’s NDCT 2019 / Schedule Y use equivalent terms: Human Pharmacology (I), Therapeutic Exploratory (II), Therapeutic Confirmatory (III) and Post-marketing (IV).
Core study-design concepts
- Randomisation — random allocation removes selection bias and balances confounders across groups.
- Blinding (masking) — single / double / triple blind; reduces performance and assessment bias.
- Control — placebo or active comparator; parallel vs crossover designs.
- Hypothesis — superiority, non-inferiority or equivalence.
- Endpoints — primary, secondary and surrogate, all defined a priori.
- Analysis sets — intention-to-treat (ITT) vs per-protocol; Type I (α) and Type II (β) errors and statistical power.
Ethical foundations
Modern research ethics grew out of past abuses (Nazi experiments; the Tuskegee syphilis study), through successive safeguards:
| Milestone (year) | Contribution |
|---|---|
| Nuremberg Code (1947) | First code on human experimentation; voluntary consent is essential (10 points). |
| Declaration of Helsinki (1964) | WMA ethical principles for medical research; revised through 2013 (Fortaleza) and 2024. |
| Belmont Report (1979) | Three principles — respect for persons, beneficence, justice. |
| CIOMS / ICMR / ICH-GCP | International and national operational guidelines for ethical trial conduct. |
ICH and GCP
The ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use; until 2015 “Conference”) was founded in 1990 and became a Swiss legal entity in 2015. It harmonises regulatory requirements across the founding regions — EU, USA (FDA) and Japan (MHLW) — to avoid duplication, speed patient access and reduce unnecessary animal/human testing. Its guidelines are grouped as:
- Q — Quality (stability, impurities, GMP, quality risk management).
- S — Safety (nonclinical toxicology, safety pharmacology, carcinogenicity).
- E — Efficacy (clinical studies). Good Clinical Practice is ICH E6 — the international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve human subjects.
- M — Multidisciplinary (e.g. the MedDRA dictionary, CTD format).
Exam tip: Phase I = healthy volunteers, safety/MTD; Phase II = efficacy & dose-finding; Phase III = confirmatory RCT for approval; Phase IV = post-marketing. GCP = ICH E6. Nuremberg → voluntary consent; Helsinki → WMA principles; Belmont → respect, beneficence, justice. Know the India/NDCT equivalent phase names.
Clinical research is simply ethics plus method, applied in sequence: prove safety, then efficacy, then watch the real world — all under GCP. Anchor the phases and the ethical milestones, and every later topic (consent, protocol, monitoring, safety reporting) is just detail hung on this frame.